N/A
N=11
Addressing Violence and HIV Care Among Transgender Women
Acceptability of Health Care · HIV Infections
Bottom Line
View on ClinicalTrials.gov: NCT04813484 ↗Enrolled (actual)
11
Serious AEs
0.0%
Results posted
Apr 2025
Primary outcome: Primary: Acceptability Quantitative — 3.5 score on a scale
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- Kickin it with the Gulz (Behavioral)
- Age
- Adult, Older Adult · 18+ yrs
- Sex
- Male
- Sponsor
- University of Michigan
- Primary completion
- May 2023
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Acceptability Quantitative |
3.5 | — |
Summary
This project seeks to adapt and pilot a trauma-informed combination intervention named 'Kickin' it with the Gurlz' that was designed with, for, and by transgender women of color to improve HIV care continuum outcomes. The intervention components include a violence and gender affirmation screening tool, a peer-led adaptation of Seeking Safety, and individual-level peer navigation sessions. The project will examine the feasibility, acceptability, and preliminary promise of the multicomponent by conducting a one-arm pilot with 30 transgender women of color who have a history of trauma. Participants will complete baseline, immediate post-intervention, and 3-month follow up assessments.
Eligibility Criteria
Inclusion Criteria
- At least 18 years old
- Assigned male at birth; identifies as female, transgender woman, or another feminine gender identity
- Self-identifies as a person of color (any racial/ethnic identity except non-Hispanic white)
- Self-reports as HIV-positive
- History of trauma (i.e., endorses at least 2 items on the adapted Trauma History Screener which includes IPV and experiencing or witnessing other forms of violence for transgender women
- Living or willing to travel to Detroit
- English-speaking
- Willing and able to provide informed consent.
Exclusion Criteria
- Evidence of severe cognitive impairment or active psychosis that may impede ability to provide fully informed consent
Data sourced from ClinicalTrials.gov (NCT04813484). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.